推荐产品
品質等級
化驗
≥98% (HPLC)
形狀
powder
儲存條件
desiccated
顏色
white to beige
溶解度
H2O: 10 mg/mL, clear
儲存溫度
−20°C
InChI
1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)
InChI 密鑰
QHATUKWEVNMHRY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
應用
Almotriptan at an oral dose of 12.5 mg, is recommended to be safe for treating migraine.
Almotriptan is a serotonin 5HT-1B/1D-receptor agonist; antimigraine.
生化/生理作用
Almotriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine. Almotriptan has low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors while affinity for 5-HT receptors other than 5-HT(1B/1D) is substantially lower. Affinity for 5-HT(7) and 5-HT(1A) receptors was approximately 40 and 60 times lower than that for 5-HT(1B/1D) receptors, respectively.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Long?term Efficacy and Safety of Oral Almotriptan: Interim Analysis of a 1?Year Open Study
Headache, 41(1), 57-62 (2001)
Acta pharmaceutica (Zagreb, Croatia), 70(2), 239-247 (2020-01-20)
The introduction of the second generation triptans in clinical and experimental practice was a major progress in the pharmacotherapy of migraine. Frovatriptan is a second generation triptan with strong 5-HT1B/1D serotonergic agonism and low 5-HT1A/7 receptor affinity, while almotriptan possesses
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
Neurology, 57(10), 1811-1817 (2001)
International journal of molecular sciences, 21(8) (2020-04-23)
The efforts for therapeutic targeting of the aryl hydrocarbon receptor (AhR) have emerged in recent years. We investigated the effects of available antimigraine triptan drugs, having an indole core in their structure, on AhR signaling in human hepatic and intestinal
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门